Insights on the Peripheral Arterial Disease Therapeutics Global Market to 2027 – Featuring AstraZeneca, Sanofi and TheraVasc Among Others – ResearchAndMarkets.com

Insights on the Peripheral Arterial Disease Therapeutics Global Market to 2027 – Featuring AstraZeneca, Sanofi and TheraVasc Among Others – ResearchAndMarkets.com




Insights on the Peripheral Arterial Disease Therapeutics Global Market to 2027 – Featuring AstraZeneca, Sanofi and TheraVasc Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Peripheral Arterial Disease (PAD) Therapeutics – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Amid the COVID-19 crisis, the global market for Peripheral Arterial Disease (PAD) Therapeutics estimated at US$776.4 Million in the year 2020, is projected to reach a revised size of US$1.1 Billion by 2027, growing at a CAGR of 4.7% over the period 2020-2027.

The U.S. Market is Estimated at $228.7 Million, While China is Forecast to Grow at 4.4% CAGR

The Peripheral Arterial Disease (PAD) Therapeutics market in the U.S. is estimated at US$228.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$189.1 Million by the year 2027 trailing a CAGR of 4.4% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Select Competitors (Total 23 Featured):

  • AstraZeneca Plc.
  • Bayer HealthCare Pharmaceuticals
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Proteon Therapeutics, Inc.
  • Sanofi S.A.
  • Symic Bio, Inc.
  • TheraVasc, Inc.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • PAD – A Prelude
  • Recent Market Activity
  • PAD Statistics
  • Critical Limb Ischemia – An Insight
  • High Costs – A Cause of Concern
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Aging – A Key Driver
  • High Diabetes Incidence Worldwide: Key Market Opportunity for PAD Therapeutics

4. GLOBAL MARKET PERSPECTIVE

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/8tqgxu

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900